Biotech RadarJobs updated

COMPANY

Parvus Therapeutics

parvustx.com ↗

Clinical Phase 1

Keywords: immunology autoimmune disease Inflammatory Bowel Disease Primary Biliary Cholangitis PVT401 PVT201

Profile checked Oct 10, 2026

2Trials (company is sponsor)

Timeline

  1. Trial start 1: A Phase 1 Study of PVT401 in Healthy Subjects source ↗
  2. Trial start Phase 1: Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC) source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 2

RecordTitlePhaseStatusStartPrimary completion
NCT07423000A Phase 1 Study of PVT401 in Healthy Subjects1RecruitingApr 13, 20262027-11 (estimated)
NCT06798454Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC)Phase 1CompletedOct 15, 2024Apr 23, 2025 (actual)
Feedback